These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3583551)

  • 21. Serum creatinine in cyclosporin-induced remission of steroid-resistant nephrotic syndrome.
    Miller C; Feutren G; Schiess W; von Graffenried B
    Lancet; 1990 Jun; 335(8701):1352. PubMed ID: 1971415
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pathogenesis of immune glomerulonephritis].
    Rougier JP; Ronco P
    Rev Prat; 2003 Nov; 53(18):1998-2004. PubMed ID: 15008213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fractional excretion of protein: a marker of the efficacy of cyclosporine A treatment in nephrotic syndrome.
    Zietse R; Wenting GJ; Kramer P; Schalekamp MA; Weimar W
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):280-4. PubMed ID: 3381284
    [No Abstract]   [Full Text] [Related]  

  • 24. [Circulating immune complexes in glomerulonephritis patients].
    Diadyk AI; Siniachenko OV; Nikolenko IuI; Iarovaia NF; Khomenko MV
    Vrach Delo; 1986 Aug; (8):94-7. PubMed ID: 3776174
    [No Abstract]   [Full Text] [Related]  

  • 25. Cyclosporine A for treatment of nephrotic syndromes.
    Brandis M; Burghard R; Leititis J; Zimmerhackl B; Hildebrandt F; Helmchen U
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):275-9. PubMed ID: 3381283
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of kidney glomerular diseases with cytostatics].
    Lorenzen I; Brun C; Balslov JT; Jensen KB; Jorgensen F; Jorgensen HE; Thomsen A
    Nord Med; 1970 Nov; 84(48):1533-4. PubMed ID: 5486034
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunologic bases of glomerular nephropathy].
    Humair L
    Helv Med Acta Suppl; 1972; 52():1-75. PubMed ID: 4115338
    [No Abstract]   [Full Text] [Related]  

  • 28. [The immuno-depressive agents in nephrology. Trial treatments of chronic primary glomerular diseases].
    Lagrue G; Bariéty J; Halpern B; Milliez P
    Presse Med (1893); 1967 Sep; 75(35):1779-81. PubMed ID: 6054132
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclosporine and other therapy-resistant nephrotic syndrome.
    van Hooff JP; Leunissen KM; Havenith MG; Bosman FT
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):293-6. PubMed ID: 3381286
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anti-inflammatory activity of glucocorticoids in nephrology].
    Nykula TD; Bondur VV; Moĭseienko VO; Aleksieieva NH
    Lik Sprava; 2013; (5):94-8. PubMed ID: 24605641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fibrillary glomerulonephritis].
    Varshavskiĭ VA; Golitsyna EP
    Arkh Patol; 2008; 70(5):31-4. PubMed ID: 19137781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunologic problems of glomerulonephritis].
    Dutz H; Philipp H
    Z Arztl Fortbild (Jena); 1971 Jun; 65(11):554-60. PubMed ID: 5570284
    [No Abstract]   [Full Text] [Related]  

  • 33. Idiopathic immune complex glomerulonephritis in dogs with multisystem involvement.
    Jeraj KP; Vernier RL; Polzin D; Klausner JK; Osborne CA; Stevens JB; Michael AF
    Am J Vet Res; 1984 Sep; 45(9):1699-705. PubMed ID: 6238560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pattern of steroid resistant nephrotic syndrome in children living in the kingdom of Saudi Arabia: a single center study.
    Kari JA; Halawani M; Mokhtar G; Jalalah SM; Anshasi W
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):854-7. PubMed ID: 19736491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unilateral renal vein thrombosis and the nephrotic syndrome.
    Moore HL; Katz R; McIntosh R; Smith F; Michael AF; Vernier RL
    Pediatrics; 1972 Oct; 50(4):598-608. PubMed ID: 5073010
    [No Abstract]   [Full Text] [Related]  

  • 36. [Physiopathological basis and therapeutic results of heparin treatment in some glomerular nephropathies with nephrotic syndrome].
    Campanacci C; Previato G
    G Clin Med; 1974 Apr; 55(4):273-95. PubMed ID: 4452438
    [No Abstract]   [Full Text] [Related]  

  • 37. [The possible approaches to the theoretical validation of the use of cytostatics and corticosteroids in treating glomerulonephritis].
    Ivanov AA; Shilov EM; Gladskikh OP; Krasnova TN; Karpukhin VV; Gitel' EP; Pal'tsev MA
    Ter Arkh; 1993; 65(6):23-6. PubMed ID: 8378841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis.
    Opastirakul S; Chartapisak W
    J Med Assoc Thai; 2006 Dec; 89(12):2145-9. PubMed ID: 17214070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment results in various morphological patterns of glomerulonephritis].
    Riabov SI; Stavskaia VV
    Ter Arkh; 1984; 56(9):97-101. PubMed ID: 6515557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating immune complexes in steroid sensitive nephrotic syndrome.
    Bakkaloğlu A; Saatçi U
    Turk J Pediatr; 1982; 24(1):3-11. PubMed ID: 7112690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.